Inflammatory markers of CHMP2B-mediated frontotemporal dementia

J Neuroimmunol. 2018 Nov 15:324:136-142. doi: 10.1016/j.jneuroim.2018.08.009. Epub 2018 Aug 17.

Abstract

Histopathological studies and animal models have suggested an inflammatory component in the pathomechanism of the CHMP2B associated frontotemporal dementia (FTD-3). In this cross-sectional study, serum and cerebrospinal fluid were analyzed for inflammatory markers in CHMP2B mutation carriers. Serum levels of CCL4 were increased throughout life. Serum levels of IL-15, CXCL10, CCL22 and TNF-α were significantly associated with cognitive decline, suggesting a peripheral inflammatory response to neurodegeneration. CSF levels of sTREM2 appeared to increase more rapidly with age in CHMP2B mutation carriers. The identification of a peripheral inflammatory response to disease progression supports the involvement of an inflammatory component in FTD-3.

Keywords: Autosomal dominantly inherited frontotemporal dementia; CHMP2B; Chromosome 3-linked frontotemporal dementia (FTD-3); Inflammation; TREM2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Biomarkers / blood
  • Biomarkers / cerebrospinal fluid
  • Cross-Sectional Studies
  • Endosomal Sorting Complexes Required for Transport* / genetics
  • Female
  • Frontotemporal Dementia / blood*
  • Frontotemporal Dementia / cerebrospinal fluid*
  • Frontotemporal Dementia / genetics
  • Humans
  • Inflammation Mediators / blood*
  • Inflammation Mediators / cerebrospinal fluid*
  • Male
  • Middle Aged
  • Mutation / genetics

Substances

  • Biomarkers
  • CHMP2B protein, human
  • Endosomal Sorting Complexes Required for Transport
  • Inflammation Mediators